ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ACUR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/21	22 : 32	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/11/05	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/10/03	00 : 16	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/08/10	03 : 44	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/07/27	04 : 52	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/06/05	00 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/05/15	21 : 00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/05/15	05 : 40	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/02/15	00 : 53	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/02/03	00 : 27	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/11	07 : 13	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/12/22	02 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/12/07	04 : 35	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/04	01 : 42	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/10/13	01 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/26	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/01	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/01	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/31	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/17	00 : 20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/11	01 : 17	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/07/29	05 : 41	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)